Influence of COVID-19 on the Refined Management of Medical Quality:a Case Study of Thyroid Malignancy Patients Undergoing Sur-gery

李小艳,王莉,付艳玲,李亚男,张戟,李颖川
DOI: https://doi.org/10.13912/j.cnki.chqm.2023.30.3.09
2023-01-01
Abstract:Objective To explore the treatment characteristics of patients undergoing thyroid malignancy surgery in Shanghai municipal hospitals under the epidemic situation of COVID-19, and put forward suggestions for improvement. Methods The information of thyroid malignancy surgery patients admitted to 36 municipal hospitals in Shanghai from January 1, 2020 to December 31, 2020 was collected, and compared with the data of the same period in 2019.SPSS 21.0 software was used for statistical analysis. Results Due to the impact of COVID-19, the number of discharged thyroid malignancy surgery patients from 36 municipal hospitals in Shanghai reached 21 710 in 2020, a decrease of 3.96% compared with the same period in 2019. The average length of stay was 5.00 days, 2.88% longer than the same period in 2019. The average cost was 19 716.63 Yuan, an increase of 5.43% compared with the same period in 2019. The average drug cost was 2 561.06 Yuan, increased by 7.41% compared with the same period in 2019, respectively. The average consumption cost was 3 817.46 Yuan, which increased by 10.94% compared with the same period in 2019, respectively. Conclusion The COVID-19 epidemic has a certain impact on the medical service capacity, medical service efficiency and medical cost control of thyroid malignancy surgery patients in Shanghai municipal hospitals. General hospitals need to improve the capacity of medical services; specialized hospitals need to improve the efficiency of medical services; traditional Chinese medicine hospitals need to strengthen the consciousness of cost control.
What problem does this paper attempt to address?